Efficacy and Safety of a Novel Herbal Medicine in the Treatment of Irritable Bowel Syndrome: A Randomized Double-Blinded Clinical Trial
Autor: | Mahmoud Omidi, Malihe Akhavan, Ghasem Bordbar, Saeed Shoja, Mohammad Bagher Miri |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Article Subject medicine.drug_class MEDLINE RC799-869 03 medical and health sciences 0302 clinical medicine Antiseptic Internal medicine Medicine Irritable bowel syndrome Hepatology Carminative business.industry Gastroenterology Diseases of the digestive system. Gastroenterology medicine.disease Clinical trial Tolerability 030220 oncology & carcinogenesis Clinical Study 030211 gastroenterology & hepatology Antispasmodic business Softgel medicine.drug |
Zdroj: | Gastroenterology Research and Practice Gastroenterology Research and Practice, Vol 2020 (2020) |
ISSN: | 1687-630X 1687-6121 |
Popis: | Background. The unresponsiveness to conventional pharmacological treatments and their side effects have led patients with irritable bowel syndrome (IBS) to use complementary and alternative medicine such as herbal remedies. Beside, Zataria multiflora Boiss (ZM), Trachyspermum ammi L. (TA), and Anethum graveolens L. (AG) are being used as an antiseptic, carminative, and antispasmodic in traditional medicine. This trial investigated the efficacy and safety of a combination of ZM, AG, and TA essential oils in the treatment of IBS. Method. The present study was a randomized double-blind clinical trial with parallel groups in Iran. Patients in the control arm received three tablets of 10 mg hyoscine butylbromide daily for two weeks, and the intervention arm was daily treated with two 250 mg softgel capsules containing 180 mg of essential oils of ZM, AG, and TA for two weeks. Primary outcomes were the response rates based on the IBS Symptom Severity Scale (IBS-SSS), IBS Adequate Relief (IBS-AR), and IBS Global Assessment Improvement (IBS-GAI) at the end and two weeks after the end of the intervention. Secondary outcomes were the improvement rates in IBS-SSS scores, improving the quality of life, safety, and tolerability. Results. The posttreatment improvement percentage based on IBS-AR, IBS-GAI, and IBS-SSS scales was 83.9%, 75%, and 87% in the intervention group and 37.9%, 27.5%, and 34.4% in the control group, respectively (P<0.001). Also, the improvement of the quality of life in the herbal medicine arm was significantly more than that in the control arm (P<0.001). Conclusions. According to the results, the herbal medicine investigated in this study can be considered an appropriate alternative treatment for IBS. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |